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Introduction: Proper selection of patient and stent-graft combinations in endovascular aneurysm repair (EVAR) depends
on knowledge and experience with the different types of stents that have to be adapted to the patient’s unique abdominal
aortoiliac anatomy. The aim of this study was to analyze the consistency and variance in EVAR suitability assessment
between clinicians.
Methods: Worksheets that contained anatomic data derived from computed tomography scans and angiography were
compiled for 202 patients. Five clinicians, all experienced in EVAR surgery, assessed the anatomic data on the worksheets
for suitability for three types of stent-grafts. The obtained 3030 assessments represented a quantification of the likelihood
of success the clinician expected for effective and durable sealing and fixation of the stent-graft in EVAR. The Delphi
method was used to determine consensus in the thinking process among clinicians, and  analysis was used to determine
the proportion of variances in the assessment result between clinicians.
Results: With the Delphi method, Cronbach  values of 0.87, 0.87, and 0.90 were reached for the three types of
stent-grafts in the second assessment round. The individual clinician-group correlation in round two was between 0.69
and 0.86 for clinicians 1, 2, 3, and 4. Between clinician 5 and the others, correlation varied between 0.43 and 0.64. The
 values ranged between 0.32 and 0.51 among clinicians 1, 2, and 3. Between clinician 5 and the others,  values between
0.08 and 0.29 were reached.
Conclusion: EVAR suitability estimation in a cohort of patients is highly consistent in a group of experienced clinicians. The
EVAR suitability estimation at the individual patient level varies substantially between clinicians, however. Aggregating expert
opinions in abdominal aortic aneurysm anatomic suitability assessment for EVAR had the opportunity to replace individual
clinician decision diversification in a more solid and consistent group decision process. (J Vasc Surg 2006;43:671-6.)Endovascular aneurysm repair (EVAR) requires preop-
erative measurement to precisely define the aneurysm mor-
phology and subsequently select the appropriate type of
stent-graft. EVAR suitability or “likelihood of success” is a
result of the combination of aneurysm morphology and
thorough knowledge and experience with different types of
stent-grafts. Preoperative EVAR suitability assessment is an
important factor in determining successful aneurysm exclu-
sion, minimizing intraoperative difficulties, and endeavor-
ing the likelihood of attaining EVAR durability.1-9
Extracting EVAR decision algorithms to quantify the
likelihood of success from a large panel of experienced
clinicians has the potential to become an EVAR suitability
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individual clinician’s uncertainty. A condition for develop-
ing applicable EVAR suitability algorithms is a high consis-
tency in decision-making strategy between individual clini-
cians for each type of stent-graft.
The aim of the present study was to determine consis-
tency and variance in the preoperative assessment of EVAR
suitability between experienced clinicians.
METHODS
Anatomic data from 202 abdominal aortoiliac aneu-
rysm (AAA) patients from two high-volume teaching hos-
pitals were included in this study. All 202 patients were
presented for EVAR assessment in the period 1999 to 2001
(Table I). For all patients, data from plain and contrast-
enhanced computed tomography (CT), or calibrated intra-
arterial digital subtraction angiography (iaDSA), or both,
were always available.
In both clinics, a minimum of at least three clinicians
performed the standardized measurement procedure of all
202 AAAs. In three cases of neck configuration discrepancy,
twomore clinicians were involved in the measurement proce-
dure until consensus was reached.10 A standardized worksheet
was used to divide each AAA into 10 segments: suprarenal
aorta, infrarenal aortic neck, aneurysm, aortic bifurcation,
right and left common iliac artery, right and left external iliac
artery, and right and left common femoral artery (Fig 1). Six
characteristics were recorded for each segment: diameter,
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angulation, and shape (Table II).
When both were available, we preferred images of CT
scans for diameter measurement and iaDSA for length
measurement. Diameter was measured from intima to in-
tima. The percentage of thrombus and percentage of calcifi-
cation were defined as the percentage of the circumference
of the total segment assessed from plain CT scans and
contrast-enhanced CT-scans, respectively; angulation was
defined as the sharpest central lumen line angulation in one
or between two segments.
A total of 72 different criteria were used to describe the
full anatomic characteristics of each individual AAA. The
outcomes of all these measurements were tabulated on an
AAA stent-grafting assessment worksheet (Table II). Accord-
ing to the aim of this study, we removed other patient char-
acteristics such as age and comorbidity from the worksheet,
providing the experts with only the numeric anatomic AAA
data to assess the anatomic suitability for EVAR.
Suitability assessment. One interventional radiolo-
gist and two vascular surgeons from one hospital and one
Table I. Patient demographics
Hospital I
Patients (n) 100
Mean age (years) (range) 71 (51-92
Male gender (%) 94
Mean average sac diameter (mm) (range) 56 (18-90
EVAR yes/no (%) 70/30
Fig 1. Infrarenal abdominal aortic aneurysm segments (Eurostar
worksheet).vascular surgeon and one radiologist from two other hos-pitals were part of this study. Each clinician had an individ-
ual EVAR experience of at least 100 procedures. The five
clinician independently assessed EVAR suitability by using
the numeric anatomic data of these 202 AAA worksheets.
All of the commercially available configurations of three
stent-grafts—the Talent standard, the Talent custom-made,
and the AneuRx (Medtronic AVE, Santa Rosa, Calif)—were
available for selection.
EVAR suitability was defined as the clinician’s expec-
tation for the likelihood of an effective and durable sealing
and fixation preventing proximal or distal leakage (type I
endoleak) or stent-graft disconnection (type III endoleak).
Because each AAA consisted of 10 segments, the overall
suitability score for EVAR consisted of the aggregation of
the score of these 10 segments by the individual clinician.
We did not analyze the segmental information in this study.
The suitability for EVAR expressed by each clinician
had to be rated on a 0 to 100 scale, between very suitable (0
to 49) and not suitable (100). To categorize the suitability,
five clinically relevant asymmetrical groups (Fig 2) were
defined for this study in dialogue with three other EVAR
specialists not related to the assessments. The more difficult
cases were rated in three of the five categories, ranging from
50 to 99, rendering the clinical relevancy. For intermediate
or highly suitable cases, no subcategorization was made,
thereby reducing the total number of categories needed in
five. Based on the criteria and the available stent-grafts, the
clinicians used the data from 202 patients to make a total of
3030 EVAR suitability assessments in the first round.
Statistical analyses. The Delphi method11,12 was used
to measure the consensus in EVAR suitability estimation for
the 202 different AAA cases. Each worksheet was seen as an
item of an “assessment questionnaire.” The five clinicians
evaluated each itemwith a suitability score for EVAR for each
of the three stent-grafts separately. Applying the Delphi
method, we created five clinician-ranking scores expressing
the likelihood of success on a scale from0 to 100 for each item
for each type of stent-graft (Fig 3). We used Cronbach’s  as
a coefficient for internal consistency between the five clinician-
ranking scores. The more the five clinicians were equal in
their way of ranking EVAR suitability for the 202 work-
sheet cases, the closer the Cronbach  value was to 1.0. A
Cronbach  value of 0.7 to 0.8 is regarded as satisfactory
consistency between clinicians. For clinical application, val-
ues near 0.90 are recommended.11,12 To determine indi-
vidual clinician-group correlation, we used the inter-item
Hospital II Total P
102 202 NS
71 (48-89) 71 NS
94 94 NS
58 (35-90) 57 (18-90) NS
102/0 172/30 .05)
)correlation matrix.11
suita
estim
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each clinician. In the first round, all 202 assessments had to
be made. In the second round, the clinicians had to reassess
their outliers, which were defined as EVAR suitability as-
sessments that deviated more than one EVAR suitability
category (Fig 2) of the clinician’s mean EVAR suitability
score. In this second round, clinicians were blinded for the
outcome of their assessments in the first assessment round.
They knew, however, that the assessment they made was
different from the group assessment and reassessment was
asked. If an individual assessment after the second round
persistently deviated more than twice the standard error of
the mean, the chief author discussed the case with the
clinician, using the segmental scoring information as a
check for misinterpretation of numeric anatomic data. If a
misinterpretation was excluded, the suitability assessment
of a case was considered as a consistent outlier. After the
second round, the Delphi process was terminated because
clinically applicable Cronbach  values were reached.
With the  method, clinical relevant variances in the
         EVAR suitability
0-49 %   
Very high suitable ---------------------------------------------------
Fig 2. The suitability for endovascular aneurysm repair is d
50 to 94 (intermediate to low suitable); 95 to 98 (very low
Fig 3. Consistency and variance of assessments betwe
decision making but also and high variance in suitabilityoutcome of suitability assessment between clinicians forindividual patient and stent-graft combinations were deter-
mined. The following nomenclature of Landis and Koch,13
was used: poor (,0), slight (, 0 to 0.20), fair (, 0.21 to
0.40), moderate (, 0.41 to 0.60), substantial (, 0.61 to
0.80), and almost perfect (, 0.80 to 1.00) agreement.
Four categories of overall EVAR suitability assessments
were defined to calculate  values: group 1, 50; group 2,
50 to 94; group 3, 95 to 99; group 4, 100. This redefinition
was necessary because our original categorization in five
groups (Fig 2) did not have any assessment scores in the 99
groups for some clinicians, so  could not be calculated.
The statistical analyses were performed with SPSS ver-
sion 12.0 (SPSS Inc., Chicago, Ill) for Windows (Microsoft,
Redmond, Wash).
RESULTS
In round one for the Talent standard, Talent custom-
made, and AneuRx stent-graft assessments, Cronbach 
values of 0.79, 0.81, and 0.85, respectively, were found.
The second round increased the Cronbach  values to
  
     50-94%       95-98     99  100% 
---------------------------------------------------------      not suitable 
d in five categories: 0 to 49 (high to intermediate suitable);
ble), 99 (practically not suitable), 100 (not suitable).
dividual clinicians. Example of a high consistency in
ation per assessment between A, B, C, D, and E. rating
 
--------
ivideen in0.87, 0.87, and 0.90, respectively.
, digita
JOURNAL OF VASCULAR SURGERY
April 2006674 Rödel et alThe individual clinician group correlation over two
Delphi iterations is presented in Table III. In all three
stent-graft assessments, the individual clinician-group
correlation in round two was between 0.69 and 0.86 for
clinicians 1, 2, 3, and 4. Compared with clinician 5, a
persisting clinician-group correlation of0.64 was seen.
The  values (Table IV) ranged between 0.32 and
0.51 among clinicians 1, 2, and 3. Between clinician 5
and the others,  values between 0.08 and 0.29 were
Table II. AAA–EVAR assessment worksheet. A, Aneurysm cla
Diameter
CT
MRA DS
D 1
D 2a
D 2b
D 2c
D 3
D 3a
D 4
D 5a
D 5b
D 6a
D 6b
D 7a
D 7b
CT, computed tomography; MRA, magnetic resonance angiography; DSA
Table III. Individual clinician-group correlation over two
Talent standard
Round 1 Round 2 R
Clinician 1 0.74 0.83
Clinician 2 0.69 0.79
Clinician 3 0.48 0.70
Clinician 4 0.61 0.72
Clinician 5 0.34 0.43reached.For eight of 30 clinician-clinician comparisons, the 
value was moderate, for only one of 30 was the  value
substantial at 0.62, which indicates an agreement tendency.
DISCUSSION
This study clearly demonstrated that aggregating ex-
pert opinions in AAA anatomic suitability assessment for
EVAR had the opportunity to replace individual clinician
decision diversification with a more solid and consistent
ation (Eurostar) B, Neckshape16 C, Measurements (mm)
Tromb.
% A
Calc.
% A Height
CT
MRA DSA
H 1
H 2
H 3
H 4a
H 4b
Angulation Angle o Angle o
Aortic neck
Aneurysm
Right com iliac
Left com iliac
Right ext iliac
Left ext iliac
l subtraction angiography.
phi iterations
alent custom made AneuRx
1 Round 2 Round 1 Round 2
0.84 0.82 0.86
0.80 0.75 0.83
0.69 0.64 0.71
0.75 0.64 0.74
0.43 0.50 0.64ssific
ADel
T
ound
0.78
0.71
0.51
0.64
0.34group decision process.
rafts,
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timation in a group of AAAs was satisfyingly consistent
between experienced clinicians. The high Cronbach  val-
ues indicated a clinically applicable equivalent thinking
process or group consensus. Only for clinician 5 was the
clinician-group correlation low. This indicated that the
decision-making strategy of clinician 5 was a consistent
outlier compared with the other four clinicians. Clinician 5
had a tendency to rank EVAR suitability in extreme cate-
gories. The other four clinicians had a more deliberate
assessment of the AAA data for EVAR.
The  analysis demonstrated that the estimation on the
level of each individual patient frequently varies one, or
even more, categories between clinicians. Clearly, estimat-
ing the level of EVAR suitability for an individual AAA
anatomy dataset is mostly an expression of objective clinical
knowledge, intuition, and the clinician’s past experience.
From a patient perspective, this indicates that estimating
the chance of effective and durable sealing and fixation of
the stent-graft depends not only on the unique morphol-
ogy of the patient but, importantly for a significant part,
also on the risk assessment of each individual clinician.
The clinicians were selected because of their educa-
tional expertise as proctors and they were familiar with
assessing numeric anatomic AAA data for EVAR as used in
this study. Also, the clinicians had different backgrounds in
their original vascular traineeship. These facts contributed
to minimize biasing of the Delphi method. As mentioned
before, the clinicians were only aware of the numeric ana-
tomic AAA data, although of course in practice, the defin-
itive decision for or against EVAR application is only pos-
sible by balancing not only the anatomic characteristics but
also themany other relevant patient characteristics. Accord-
ing to the aim of this study, acquaintance with other patient
data or reviewing the original CT or iaDSA images was not
allowed, thereby excluding, among other things, the influ-
ence of the interobserver variation of AAA measurement.10
Even high-volume AAA-EVAR teams will not develop
enough experience to offer the individual patient compre-
hensive and balanced advice on EVAR suitability for all of
the different commercially available stent-grafts. Moreover,
EVAR is a rapidly evolving technology. The frequent intro-
duction of new types of stent-grafts with their own unique
characteristics results inmore intuitive rather than knowledge-
Table IV. Accordance after EVAR suitability assessment (
standard, Talent custom, and AneuRx stent-grafts
Clinician 1 Clinic
Clinician 1 X X
Clinician 2 0.48/0.51/0.62 X
Clinician 3 0.40/0.33/0.49 0.33/0.3
Clinician 4 0.47/0.44/0.50 0.37/0.3
Clinician 5 0.11/0.09/0.29 0.09/0.0
Data correspond with Talent standard, Talent custom, and AneuRx stent-gbased decision-making in daily practice.14,15CONCLUSION
Extracting EVAR suitability decision algorithms from a
large panel of experienced clinicians has the potential to be-
come a gold standard if the algorithms are validated, easily
accessible, and continuously updated with the latest peer-
reviewed knowledge on the outcome of EVAR. The valida-
tion process of these algorithms should include future studies
comparing the ultimate clinical outcomeof individual patients
with the initial suitability assessment, supporting the hypoth-
esis that differences in preoperative suitability assessment pre-
dicted the ultimate results. Developing such a gold standard
protects patients against individual clinician misinterpretation
and against delay in the introduction of new EVAR knowl-
edge in the medical community.14,15
We are grateful to A. Stam (research assistant Medisch
Spectrum Twente) and P. Oude Groothuis (field sales
supervisor Medtronic AVE, Kerkrade, The Netherlands)
for their help with conducting and performing this study.
AUTHOR CONTRIBUTIONS
Conception and design: SGJR, RHG, JAvH, EEK, JCvdB,
JvdP, JAWT, FLM
Analysis and interpretation: SGJR, RHG, EEK, JCvdB,
JvdP, JAWT, FLM
Data collection: SGJR, RHG, JAvH, JvdP
Writing the article: SGJR, RHG, JAvH, EEK, JCvdB, JvdP,
JAWT, FLM
Critical revision of the article: SGJR, RHG, EEK, JvdP
Final approval of the article: SGJR, RHG, JAvH, EEK,
JCvdB, JvdP, JAWT, FLM
Statistical analysis: SGJR, RHG, EEK, JvdP
Obtained funding: EEK
Overall responsibility: SGJR, RHG.
REFERENCES
1. ArmonMP, Yusuf SW, Latief K, Whitaker SC, Gregson RHS, Wenham
PW, et al. Anatomical suitability of abdominal aortic aneurysms for
endovascular repair. Br J Surg 1997;84:178-80.
2. Albertini JN, Kalliafas S, Travis S, Yusuf SW, Macierewicz JA, Whitaker
SC, et al. Anatomical risk factors for proximal perigraft endoleak and
graft migration following endovascular repair of abdominal aortic an-
eurysms. Eur J Vasc Endo Surg 2000;19:308-12.
3. Carpenter JP, BaumRA, Barker CF, GoldMA,MitchellME, Velazquez
OC, et al. Impact of exclusion criteria on patient selection for endovas-
d two) between clinicians expressed in  with Talent
Clinician 3 Clinician 4
X X
X X
48 X X
47 0.23/0.19/0.31 X
27 0.14/0.11/0.23 0.09/0.08/0.18
respectively.roun
ian 2
2/0.
4/0.
8/0.cular abdominal aortic aneurysm repair. J Vasc Surg 2001;34:1050-4.
JOURNAL OF VASCULAR SURGERY
April 2006676 Rödel et al4. Sternbergh WC III, Carter G, York JW, Yoselevitz M, Money SR.
Aortic neck angulation predicts adverse outcome with endovascular
abdominal aortic aneurysm repair. J Vasc Surg 2002;35:482-5.
5. Treiman GS, Lawrence PF, Edwards WH Jr, Galt SW, Kraiss LW,
Bhirangi K. An assessment of the current applicability of the EVT
endovascular graft for treatment of patients with an infrarenal abdomi-
nal aortic aneurysm. J Vasc Surg 1999;30:68-75.
6. Sapram ESK, KarafaMT,Mascha EJ, Clair DG, Greenberg RK, Luyden
SP, et al. Nature, frequency, and predictors of secondary procedures
after endovascular repair of abdominal aortic aneurysm. J Vasc Surg
2003;37:930-7.
7. Cuypers PW, Laheij RJ, Buth J. Which factors increase the rating of
conversion to open surgery following endovascular abdominal aortic
aneurysm repair? Eur J Vasc Endovasc Surg 2000;20:183-9.
8. Dattilo JB, Brewster DC, Fan C, Geller SC, Cambria RP, Lamuraglia GM,
et al. Clinical failures of endovascular abdominal aortic aneurysm repair:
incidence, causes, and management. J Vasc Surg 2002;35:1137-44.
9. Forbes TL, DeRose G, Kribs SW, Harris KA. Cumulative sum failure
analysis of the learning curve with endovascular abdominal aortic aneu-
rysm repair. J Vasc Surg 2004;39:102-8.
10. Aarts NJM, Schurink GWH, Schultze Kool LJ, Bode PJ, van Baalen JM,vascular repair: intra- and interobserver variability of CTmeasurements.
Eur J Vasc Endovasc Surg 1999;18:475-80.
11. Balm R, Stokking R, Kaatee R, Blankensteijn JD, Eikelboom BC, van
Leeuwen MS. Computed tomographic angiographic imaging of ab-
dominal aortic aneurysms: implications for transfemoral endovascular
aneurysm management. J Vasc Surg 1997;26:231-7.
12. Graham B, Regehr G, Wright JG. Delphi as a method to establish
consensus for diagnostic criteria. J Clinical Epidemiol 2003;56:1150-6.
13. Bland JM, Altman DM. Cronbach’s alpha. BMJ 1997;314:572.
14. Landis JR, Koch GG. The measurement of observer agreement for
categorical data. Biometrics 1977;33:159-74.
15. Zarins CK, Shaver DM, Arko FR, Schubart PJ, Lengle SJ, Dixons SM.
Introduction of endovascular aneurysm repair into community practice:
initial results with a new Food and Drug Administration-approved
device. J Vasc Surg 2002;36:226-33.
16. AbelDA, BeebeHG,DedashtianMM,MortonMC,MoynahanM, Smith
LJ, et al. Preclinical testing for aortic endovascular grafts: results of a Food
and Drug Administration workshop. J Vasc Surg 2002:35:1022-8.Hermans J, et al. Abdominal aortic aneurysm measurements for endo- Submitted Sep 29, 2005; accepted Nov 28, 2005.
The JVS Ombudsman
The ombudsman’s role is to act as an advocate for authors and represent their position to the editorial staff in
relation to the process of manuscript submission, review, and publication. The ombudsman is not responsible for
evaluating the content of a manuscript or determining whether the editors made the correct decision with regard to
acceptance or rejection of the paper. If an author or other person has an unresolved complaint or question about the
editorial process of the Journal, he or she should contact Dr James S. T. Yao (Northwestern University Medical
School, Department of Surgery, 201 E.Huron Street, Suite 10-105, Chicago, IL 60611), whowill review thematter.
